<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, patients may also report anosmia and dysgeusia as early symptoms of COVID-19 [
 <xref rid="B71-ijerph-17-05904" ref-type="bibr">71</xref>]. Anosmia (loss of sense of smell) and dysgeusia (alteration of the sense of taste) are also associated with COVID-19 patients. The American Academy of Otolaryngology-Head and Neck Surgery developed the COVID-19 Anosmia Reporting Tool for clinicians to conduct a pilot study. This tool allows clinicians to submit the anosmia and dysgeusia associated COVID-19 patients. They analyzed the first 237 entries and revealed that anosmia was observed in 73% of patients prior to the diagnosis of COVID-19 and was the early symptom in 26.6% of COVID-19 patients. Conclusively, this study suggested that anosmia can be the representative symptom of COVID-19 [
 <xref rid="B72-ijerph-17-05904" ref-type="bibr">72</xref>,
 <xref rid="B73-ijerph-17-05904" ref-type="bibr">73</xref>].
</p>
